OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Recommended
Credit Saison achieves 954% ROI in a ChatGPT Enterprise pilotOpenai Making it easier for websites to express AI training preferencesOpenai Community safety report and new protections for teensOpenai Operation "Doppelganger": Russian influence activity targeting UkraineOpenai Everyday work with ChatGPT WorkOpenai Romance scams: AI-enabled romance scam workflowsOpenai
BI Leader Qlik Goes AI, Acquires AutoML Provider Big SquidThenewstack
Socket Acquires Coana to Bring Best-in-Class Reachability Analysis to Next-Gen SCASocket
Socket Acquires Coana to Bring Reachability Analysis to Every Appsec TeamSocket
Notion Acquires Automate.io for Enhanced Automation & Integration | NotionNotion So
1Password Acquires Apono | 1Password1password
Docker acquires AtomicJar, maker of Testcontainers | DockerDocker
9 Linktree Alternatives For Link-In-Bio 2022Heygen
Honeycomb Acquires Grit and Expands Leadership Team to Accelerate Customer Value and EnterpriseHoneycomb
Docker Acquires Mutagen to Invest in Docker Desktop | DockerDocker
Hugo tips: How to create author pagesNetlify
DuckDB Ecosystem Newsletter : September 2026Motherduck
Docker Acquires MCP Defender for Agentic AI SecurityDocker
Honeycomb Acquires Grit: A Strategic Investment in Pragmatic AI and Customer ValueHoneycomb
Sentry Acquires Analytics Firm Specto to Add Continuous Profiling to Mobile Application MonitoringSentry
